Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial

被引：0
|
作者：
Achim J. Kaasch
Gerd Fätkenheuer
Reinhild Prinz-Langenohl
Ursula Paulus
Martin Hellmich
Verena Weiß
Norma Jung
Siegbert Rieg
Winfried V. Kern
Harald Seifert
机构：
[1] University of Cologne,Institute for Medical Microbiology, Immunology and Hygiene
[2] University Hospital of Cologne,Department I of Internal Medicine
[3] University of Cologne,Clinical Trial Center Cologne
[4] University of Cologne,Institute of Medical Statistics, Informatics and Epidemiology
[5] University Medical Center Freiburg,Department of Medicine, Center for Infectious Diseases and Travel Medicine
[6] German Centre for Infection Research (DZIF),undefined
来源：
Trials | / 16卷
关键词：
Oral switch therapy; Intravenous; Antimicrobial; Bloodstream infection; Bacteremia; Randomized controlled trial; Pragmatic trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial
    Kaasch, Achim J.
    Faetkenheuer, Gerd
    Prinz-Langenohl, Reinhild
    Paulus, Ursula
    Hellmich, Martin
    Weiss, Verena
    Jung, Norma
    Rieg, Siegbert
    Kern, Winfried V.
    Seifert, Harald
    TRIALS, 2015, 16
  • [2] Protocol update for the SABATO trial: a randomized controlled trial to assess early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection
    Kaasch, Achim J.
    Rommerskirchen, Anna
    Hellmich, Martin
    Faetkenheuer, Gerd
    Prinz-Langenohl, Reinhild
    Rieg, Siegbert
    Kern, Winfried, V
    Seifert, Harald
    TRIALS, 2020, 21 (01)
  • [3] Protocol update for the SABATO trial: a randomized controlled trial to assess early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection
    Achim J. Kaasch
    Anna Rommerskirchen
    Martin Hellmich
    Gerd Fätkenheuer
    Reinhild Prinz-Langenohl
    Siegbert Rieg
    Winfried V. Kern
    Harald Seifert
    Trials, 21
  • [4] Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO) : an international, open-label, parallel-group, randomised, controlled, trial
    Kaasch, Achim J.
    Lopez-Cortes, Luiseduardo
    Rodriguez-Bano, Jesus
    Cisneros, Jose Miguel
    Navarro, M. Dolores
    Faetkenheuer, Gerd
    Jung, Norma
    Rieg, Siegbert
    Lepeule, Raphael
    Coutte, Laetitia
    Bernard, Louis
    Lemaignen, Adrien
    Koesters, Katrin
    MacKenzie, Colin R.
    Soriano, Alex
    Hagel, Stefan
    Fantin, Bruno
    Lafaurie, Matthieu
    Talarmin, Jean-Philippe
    Dinh, Aurelien
    Guimard, Thomas
    Boutoille, David
    Welte, Tobias
    Reuter, Stefan
    Kluytmans, Jan
    Martin, Maria Luisa
    Forestier, Emmanuel
    Stocker, Hartmut
    Vitrat, Virginie
    Tattevin, Pierre
    Rommerskirchen, Anna
    Noret, Marion
    Adams, Anne
    Kern, Winfried, V
    Hellmich, Martin
    Seifert, Harald
    LANCET INFECTIOUS DISEASES, 2024, 24 (05): : 523 - 534
  • [5] Early Oral Switch to Linezolid for Low-risk Patients With Staphylococcus aureus Bloodstream Infections: A Propensity-matched Cohort Study
    Willekens, Rein
    Puig-Asensio, Mireia
    Ruiz-Camps, Isabel
    Larrosa, Maria N.
    Gonzalez-Lopez, Juan J.
    Rodriguez-Pardo, Dolors
    Fernandez-Hidalgo, Nuria
    Pigrau, Carles
    Almirante, Benito
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (03) : 381 - 387
  • [6] Efficacy of Early Oral Switch with β-Lactams for Low-Risk Staphylococcus aureus Bacteremia
    Bupha-Intr, Olivia
    Blackmore, Tim
    Bloomfield, Max
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (07)
  • [7] Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol
    de Kretser, Dana
    Mora, Jocelyn
    Bloomfield, Max
    Campbell, Anita
    Cheng, Matthew P.
    Guy, Stephen
    Hensgens, Marjolein
    Kalimuddin, Shirin
    Lee, Todd C.
    Legg, Amy
    Mahar, Robert K.
    Marks, Michael
    Marsh, Julie
    Mcglothin, Anna
    Morpeth, Susan C.
    Sud, Archana
    Ten Oever, Jaap
    Yahav, Dafna
    Bonten, Marc
    Bowen, Asha C.
    Daneman, Nick
    van Hal, Sebastiaan J.
    Heriot, George S.
    Lewis, Roger J.
    Lye, David C.
    Mcquilten, Zoe
    Paterson, David L.
    Owen Robinson, J.
    Roberts, Jason A.
    Scarborough, Matthew
    Webb, Steve A.
    Whiteway, Lynda
    Tong, Steven Y. C.
    Davis, Joshua S.
    Walls, Genevieve
    Goodman, Anna L.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (04) : 871 - 887
  • [8] Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial
    Forde, Caroline
    McMullan, Ronan
    Clarke, Mike
    Wilson, Richard H.
    Plummer, Ruth
    Grayson, Margaret
    McDowell, Cliona
    Agus, Ashley
    Doran, Annmarie
    McAuley, Danny F.
    Thomas, Anne L.
    Barnes, Rosemary A.
    Adams, Richard
    Chau, Ian
    Coyle, Vicky
    TRIALS, 2020, 21 (01)
  • [9] Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial
    Caroline Forde
    Ronan McMullan
    Mike Clarke
    Richard H. Wilson
    Ruth Plummer
    Margaret Grayson
    Cliona McDowell
    Ashley Agus
    Annmarie Doran
    Danny F. McAuley
    Anne L. Thomas
    Rosemary A. Barnes
    Richard Adams
    Ian Chau
    Vicky Coyle
    Trials, 21
  • [10] Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH trial)
    Coyle, V.
    Forde, C.
    Adams, R.
    Barnes, R.
    Chau, I.
    Clarke, M.
    Doran, A.
    Grayson, M.
    McAuley, D.
    McDowell, C.
    Phair, G.
    Plummer, R.
    Thomas, A.
    Wilson, R.
    McMullan, R.
    ANNALS OF ONCOLOGY, 2021, 32 : S1188 - S1188
12345